AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 295: E297-E304, 2008. First published May 20, 2008; doi:10.1152/ajpendo.00581.2007
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/E297    most recent
00581.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Gaudel, C.
Right arrow Articles by Grimaldi, P. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaudel, C.
Right arrow Articles by Grimaldi, P. A.

Pharmacological activation of PPARβ promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle

Céline Gaudel,1 Chantal Schwartz,1 Christian Giordano,1 Nada A. Abumrad,2 and Paul A. Grimaldi1

1Institut National de la Santé et de la Recherche Médicale U907 and Université de Nice-Sophia Antipolis, Faculté de Médecine, Nice, France; and 2Department of Medicine, Washington University, St. Louis, Minnesota

Submitted 7 September 2007 ; accepted in final form 19 May 2008

Recent studies have shown that administration of peroxisome proliferator-activated receptor-β (PPARβ) agonists enhances fatty acid oxidation in rodent and human skeletal muscle and that muscle-restricted PPARβ overexpression affects muscle metabolic profile by increasing oxidative myofiber number, which raises the possibility that PPARβ agonists alter muscle morphology in adult animals. This possibility was examined in this study in which adult mice were treated with a PPARβ agonist, and the resulting changes in myofiber metabolic phenotype and angiogenesis were quantified in tibialis anterior muscles. The findings indicate a muscle remodeling that is completed within 2 days and is characterized by a 1.63-fold increase in oxidative fiber number and by a 1.55-fold increase in capillary number. These changes were associated with a quick and transient upregulation of myogenic and angiogenic markers. Both myogenic and angiogenic responses were dependent on the calcineurin pathway, as they were blunted by cyclosporine A administration. In conclusion, the data indicate that PPARβ activation is associated with a calcineurin-dependent effect on muscle morphology that enhances the oxidative phenotype.

myogenesis; metabolism; Type 2 diabetes



Address for reprint requests and other correspondence: P. A. Grimaldi, Inserm U907, Faculté de Médecine Université de Nice-Sophia Antipolis, 28 Ave. de Valombrose, Nice F-06107 Cedex, France (e-mail: grimaldi{at}unice.fr)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.